Publications by authors named "David Finkle"

Claim this Profile
D
Discovery of Reversible Covalent Bruton's Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib).
Timothy D Owens, Ken A Brameld, Erik J Verner, Tony Ton, Xiaoyan Li, David Finkle

J Med Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity.
Hugo G Hilton, Nimrod D Rubinstein, Peter Janki, Andrea T Ireland, Nicholas Bernstein, David Finkle

PLoS Biol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.
Lisa Choy, Thijs J Hagenbeek, Margaret Solon, Dorothy French, David Finkle

Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged and tunable residence time using reversible covalent kinase inhibitors.
J Michael Bradshaw, Jesse M McFarland, Ville O Paavilainen, Angelina Bisconte, Danny Tam, David Finkle

Nat Chem Biol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping in vivo tumor oxygenation within viable tumor by 19F-MRI and multispectral analysis.
Yunzhou Shi, Jason Oeh, Jeffrey Eastham-Anderson, Sharon Yee, David Finkle

Neoplasia· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors.
Alicia S Chung, Marcin Kowanetz, Xiumin Wu, Guanglei Zhuang, Hai Ngu, David Finkle

J Pathol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic antibody targeting of individual Notch receptors.
Yan Wu, Carol Cain-Hom, Lisa Choy, Thijs J Hagenbeek, Gladys P de Leon, David Finkle

Nature· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice.
David Finkle, Zhi Ricky Quan, Vida Asghari, Jessica Kloss, Nazli Ghaboosi

Clin Cancer Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis